Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Number of Shares Repurchased on the SIX 2nd Trading by Year
Number of Shares Repurchased on the SIX 2nd Trading Line for Capital Reduction (million shares) (M)
Novartis Number of Shares Repurchased on the SIX 2nd Trading: 77.6M in FY2025, up 0.1% from a year earlier.
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 18.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Number of Shares Repurchased on the SIX 2nd Trading Line for Capital Reduction (million shares) (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 77.6 | +0.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 77.5 | -11.4% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 87.5 | -30.7% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 126 | +311.1% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 30.7 | -5.8% | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2020 | Dec 31, 2020 | 32.6 | -45.9% | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2019 | Dec 31, 2019 | 60.3 | +158.8% | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2018 | Dec 31, 2018 | 23.3 | -64.8% | Novartis Form 20-F (0001370368-21-000006) ↗ |
| FY2017 | Dec 31, 2017 | 66.2 | +542.7% | Novartis Form 20-F (0001370368-20-000003) ↗ |
| FY2016 | Dec 31, 2016 | 10.3 | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Cite this data
StockData. (2026). Novartis Number of Shares Repurchased on the SIX 2nd Trading (M), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/buyback-shares-cancelled-m
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.